Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02310776 · ClinicalTrials.gov registry record · NA

Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound

A NA study of Breast Diseases, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
501
Enrollment target
2
Study locations

NCT02310776: Completed NA study of Breast Diseases, sponsored by Northwestern University.

NCT02310776 is a NA study of Breast Diseases that has completed, run by Northwestern University. The registered enrollment target is 501 participants, above the 255-participant average among 8 other Breast Diseases trials with a reported enrollment target (96% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02310776, a NA study of Breast Diseases, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
501 participants
Enrollment target
2
Study locations

Study Summary

Compare lesion detection of the automated breast ultrasound (ABVS) exam with the conventional handheld (HH) breast ultrasound (US) exam.

Primary Outcome

Solid lesions found on whole breast 3D supine automated breast ultrasound are compared in number and identity with solid lesions found using high resolution standard of care handheld breast ultrasound performed by physicians

Conditions Studied

Interventions

  • DEVICE Supine automated breast ultrasound scanner
  • DEVICE High-resolution handheld breast ultrasound

Study Locations (2)

Illinois

  • Northwestern Medicine - Chicago

Pennsylvania

  • Weinstein Imaging - Pittsburgh

Trial Details

FieldValue
Enrollment Target 501 participants
Start Date 2012-06
Est. Completion 2015-10
Phase NA
Northwestern University

1,209 total trials

What the finished NCT02310776 record still lists

NCT02310776 is an interventional study that assigns participants to a tested intervention. The registered 501 participants enrollment target is mid-sized for trials with a published cap, above the 255-participant average among 8 other Breast Diseases trials with a reported enrollment target (96% higher).

The record links to 1 condition, with Breast Diseases appearing as the primary indexed condition, and to 2 interventions - of which Supine automated breast ultrasound scanner is the first listed.

NCT02310776 reports a single indexed study location in Illinois, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02310776 about?

NCT02310776 is a clinical study titled "Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound". Compare lesion detection of the automated breast ultrasound (ABVS) exam with the conventional handheld (HH) breast ultrasound (US) exam.

What is the current status of trial NCT02310776?

This trial is currently completed. It is a NA study. The enrollment target is 501 participants. The study started on 2012-06. Estimated completion is 2015-10.

What conditions does trial NCT02310776 study?

This clinical trial studies the following conditions: Breast Diseases.

What interventions are being tested in trial NCT02310776?

The interventions under investigation include: Supine automated breast ultrasound scanner (DEVICE), High-resolution handheld breast ultrasound (DEVICE).

Who is sponsoring clinical trial NCT02310776?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02310776 being conducted?

This trial has 2 study locations across Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02310776's enrollment target sits among peer trials

501 2nd of 8 the highest of 8 other Breast Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04442022 · 501 participants · Phase 2

    A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

  • NCT06934525 · 501 participants · NA

    Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings

  • NCT05646381 · 502 participants · Phase 2

    A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

  • NCT05897632 · 502 participants · NA

    CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02310776, the US trial registry maintained by the National Library of Medicine. NCT02310776 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.